Reference of 6523-49-5, These common heterocyclic compound, 6523-49-5, name is 4-(1,2,4-Triazol-1-yl)aniline, its traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route.
A solution of Intermediate 11 (96mg, 0.23mmol, leq), and 4-(7No.-l,2,4-triazol-l- yl)aniline (38mg, 0.24mmol, 1.05mmol) in acetic acid (2mL) was heated at reflux. After Ih the reaction was allowed to cool to room temperature, concentrated in vacuo and treated with a saturated aqueous solution OfK2CO3 until effervescence ceased. The resulting mixture was then concentrated in vacuo to dryness to yield a brown residue. The residue was purified using flash column chromatography, eluting initially with 200:8:1 and then 100:8:1 CH2Cl2 :EtOH:NH3. The title compound was isolated as an off-white solid (48mg, 40%). Rf = 0.39 (40:8:1 CH2Cl2:Et0H:NH3). 1H-NMR (DMSCwZ6) 2.11 (s, 6H), 2.17 (s, 3H), 2.43 (m, 2H), 2.68 (t, 2H), 4.08 (t, 2H), 7.23 (m, IH), 7.56 (m, IH), 7.75 (m, 3H), 7.93 (m, 2H), 8.08 (m, 2H), 8.50 (s, IH), 8.68 (s, IH), 9.14 (s, IH), 9.92 (br. s, IH). LC-MS rt 2.08 m/z 527 ES+
Statistics shows that 4-(1,2,4-Triazol-1-yl)aniline is playing an increasingly important role. we look forward to future research findings about 6523-49-5.
Reference:
Patent; ARROW THERAPEUTICS LIMITED; WO2007/80401; (2007); A1;,
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics